课题基金 / 基金详情

Analysis of antibody-dependent cellular virus inhibition(ADCVI) against SIV-infected cells

Analysis of antibody-dependent cellular virus inhibition(ADCVI) against SIV-infected cells
针对 SIV 感染细胞的抗体依赖性细胞病毒抑制 (ADCVI) 分析
批准号:
22890040
负责人:
YAMAMOTO Hiroyuki
金额:
$2.01万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Research Activity Start-up
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

YAMAMOTO Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
艾滋病病毒中和抗体在体内急性期非无菌病毒复制控制中起关键作用。为了评估抗体介导的先天抑制对病毒感染细胞在这一过程中的作用,建立了体外抗体依赖性细胞病毒抑制(ADCVI)测定系统。抗体的病毒结合度与ADCVI相关,而与中和活性无关。为了直接估计ADCVI的贡献,我们对siv感染的猕猴被动免疫抗siv抗体,选择性地抑制ADCVI但不中和活性,这不会导致明显的病毒血症减少或在病毒基因组序列中施加选择压力。综上所述,ADCVI在体内中和基于抗体的非无菌SIV控制中的作用是有限的。
英文摘要
AIDS virus neutralizing antibodies can play a critical role in acute phase non-sterile virus replication control in vivo. To assess the contribution of antibody-mediated innate inhibitory effects on virus-infected cells within this process, an in vitro antibody-dependent cellular virus inhibition(ADCVI) assay system was established. Virus-binding avidity of antibodies correlated with ADCVI while they did not correlate with neutralizing activity. For direct estimation of ADCVI contribution, anti-SIV antibodies selectively withholding ADCVI but not neutralizing activity were passively immunized against SIV-infected macaques, which did not result in palpable viremia reduction or exertion of selective pressure in viral genome sequences. Taken together, the role of ADCVI in neutralizing antibody-based non-sterile SIV control in vivo was suggested to be limited.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
猿猴免疫缺陷病毒攻击后,显着诱导疫苗抗原特异性细胞毒性 T 淋巴细胞反应。
DOI: 10.1016/j.bbrc.2011.04.071
发表时间: 2011
期刊: Biochemical and Biophysical Research Communications
影响因子: 3.1
作者: [Takahara, Y.]
通讯作者: Y.
DOI: --
发表时间: 2010
期刊: Vaccine
影响因子: 5.5
作者: [Yamamoto H, Matano T.]
通讯作者: Matano T.
Post-infection passive immunization of SIVmac239-specific, non-neutralizing antibodies does not control virus replication in vivo
SIVmac239 特异性非中和抗体感染后被动免疫不能控制病毒体内复制
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Nakane T, Matano T, Yamamoto H.]
通讯作者: Yamamoto H.
DOI: --
发表时间: 2010
期刊: Vaccine
影响因子: 5.5
作者: [Hiroyuki Yamamoto, Tetsuro Matano]
通讯作者: Tetsuro Matano
7
    Development of new gene therapy for primary immunodeficiencies by suppressing non-specific genetic modifications
    • 批准号:
      16K19653
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.5万
    • 财政年份:
      2016
    • 负责人:
      YAMAMOTO Hiroyuki
    • 依托单位:
    BTK gene repair by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector
    • 批准号:
      26860811
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      YAMAMOTO Hiroyuki
    • 依托单位:
    Virological and immunological analysis of neutralizing SIV antibody-inducing macaques
    • 批准号:
      25860348
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2013
    • 负责人:
      YAMAMOTO Hiroyuki
    • 依托单位:
    A method to measure the movement of a knee by an angle change and the distance between thigh and tibia on stance phase of gait
    • 批准号:
      24650339
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.08万
    • 财政年份:
      2012
    • 负责人:
      YAMAMOTO Hiroyuki
    • 依托单位:
    海外基金